Home > Jones Day > Offices > Office Profile


Jones Day

  - Office Profile
 





                  Firm Logo for Jones Day
Jones Day 
Boston, Massachusetts Office
View all offices

100 High Street, 21st Floor
Boston, Massachusetts  02110-1781

(Suffolk Co.)

Telephone: (617) 960-3939
Fax: (617) 449-6999
http://www.jonesday.com



Profile Visibility
#17 in weekly profile views out of 1,953 law firms in Boston, Massachusetts
#13 in weekly profile views out of 283,716 total law firms Overall




 

Specific Practice & Industry Groups Details:
Banking & FinanceBusiness Restructuring & Reorganization
Business and Tort Litigation (USA)Financial Institutions Litigation & Regulation
Health CareIntellectual Property
Issues & AppealsLife Sciences
M&APrivate Equity
Real EstateTax


Statement of Practice Summary:
Antitrust; Competition Law; Banking Law; Finance; Business and Tort Litigation - USA; Business Restructuring; Reorganization; Capital Markets; Corporate Criminal Investigations; Employee Benefits; Executive Compensation; Energy; Environmental Law; Health Law; Safety; Financial Institutions Litigation; Regulation; Global Disputes; Government Regulation; Health Care; Insurance Recovery; Intellectual Property; Issues; Appellate Practice; Labor and Employment; Life Sciences; Mergers and Acquisitions; Private Equity; Projects and Infrastructure; Real Estate; Securities Litigation; SEC Enforcement; Tax Law; Cybersecurity, Privacy & Data Compensation.


Documents by Lawyers at this office
Subscribe to this feed

Madden v. Midland Funding, LLC: Solicitor General Recommends Against Certiorari but Explains Flaws in the Second Circuit's Controversial Decision
Traci L. Lovitt,Matthew A. (Matt) Martel,Anthony M. (Tony) Masero,Joseph B. (Joe) Sconyers, June 13, 2016
This week, the Solicitor General filed a brief recommending that the U.S. Supreme Court deny certiorari in Madden v. Midland Funding, LLC because of, among other things, the absence of a circuit split and the possibility that the appellants may still prevail in the underlying dispute after the case...

Human Drug Compounding: Trio of Documents Discuss FDA Position on the Prescription Requirement, Hospital Compounding, and Definition of "Facility"
Edgar Asebey,Maureen Bennett,Christian B. Fulda,Colleen M. Heisey,Cristiana Spontoni, June 2, 2016
FDA released three new draft guidance documents regarding its implementation of the human drug compounding requirements of Title I of the Drug Quality and Security Act, the "Compounding Quality Act." Fundamentally, the draft guidance documents describe FDA's current thinking on the...

New Federal Trade Secret Act Expands Trade Secret Rights
Kenneth S. (Ken) Canfield,Douglas L. (Doug) Clark,Randy Kay,Christopher M. (Chris) Morrison,Kelsey I. Nix, May 30, 2016
Trade secrets gained prominence as a federally protected form of intellectual property this week with the enactment of the Defend Trade Secrets Act of 2016 ("DTSA"). The DTSA provides federal civil protection against misappropriation of trade secrets. Victims of trade secret theft now...




Languages: German.


Return to the Jones Day Firm Overview


 

Complete a Client Review


Have you recently worked with this firm? Share your experience as a Client of this firm and complete a Client Review to help others make an informed choice when hiring legal counsel.
 
 

Purchase Report

Buy an atVantage Firm Profile for insight into a law firm's litigation, bankruptcy, corporate transaction and patent prosecution experience.
 
 

Compare this Firm

Compare this firm to other firms in your Favorites.
 

Add firm to Favorites

As a registered user of martindale.com Connected, you can add firms to your list of Favorites. You can securely add comments and compare the firms in your Favorites.